Table 1 Availability of anti-malarials and malaria blood testing, among anti-malarial stockists
From: The malaria testing and treatment landscape in the southern Lao People’s Democratic Republic (PDR)
Public health facility | Community health worker | Public sector total | Private for-profit facility | Pharmacy | General retailer | Private sector total | |
|---|---|---|---|---|---|---|---|
% (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
Proportion of outlets stocking: | N = 91 | N = 145 | N = 236 | N = 56 | N = 309 | N = 23 | N = 394 |
Any national first-line ACT (AL) | 99.5 (97.1, 99.9) | 83.1 (72.3, 90.3) | 88.8 (82.0, 93.2) | 63.3 (45.8, 77.9) | 51.7 (40.0, 63.2) | 3.1 (0.5, 17.0) | 40.8 (31.1, 51.2) |
Chloroquine | 4.6 (1.9, 10.6) | 19.2 (11.2, 31.0) | 14.1 (8.9, 21.7) | 49.3 (33.7, 65.0) | 74.6 (67.0, 80.9) | 96.9 (83.0, 99.5) | 77.6 (71.2, 83.0) |
Primaquine | 6.7 (1.57, 24.17) | 0.0 – | 2.8 (0.6, 12.13) | 0.0 – | 0.0 – | 0.0 – | 0.0 – |
Oral artemisinin monotherapy | 0.0 – | 0.0 – | 0.0 – | 2.7 (0.5, 14.5) | 0.0 – | 0.0 – | 0.3 (0.0, 1.6) |
N = 91 | N = 154 | N = 255 | N = 58 | N = 327 | N = 30 | N = 424 | |
Any malaria blood testing | 90.8 (77.4, 96.6) | 78.4 (66.7, 86.9) | 82.4 (74.2, 88.3) | 77.0 (64.3, 86.2) | 55.7 (44.2, 66.7) | 6.1 (1.6, 20.6) | 43.5 (34.2, 53.3) |
Malaria microscopy | 23.1 (14.9, 34.0) | 0.0 – | 7.3 (4.6, 11.4) | 16.0 (9.4, 25.8) | 0.3 (0.0, 1.7) | 0.0 – | 1.7 (1.0, 2.9) |
Rapid diagnostic tests | 85.4 (73.5, 92.5) | 78.4 (66.7, 86.9) | 80.6 (72.3, 86.9) | 77.0 (64.3, 86.2) | 55.7 (44.2, 66.7) | 6.1 (1.6, 20.6) | 43.5 (34.2, 53.3) |